Distinctly higher ratios of MMP-9/MMP-2 and activated MMP-9/proMMP-9 are found in the sera of achalasia patients than the controls, and MMP-9 can be used as an innate immune effector for binding to novel substrates in achalasia [9]. This evidence concerns the gene MMP9 and Achalasia.